The Asian Scientist 100
Lu Ke
Institution
Chinese Academy of Sciences
Country
China
Field
Materials Sciences
Lu is the winner of the 2020 Future Science Prize (Physical Science Prize) for discovering and synthesizing a superior nanotwinned structure and gradient nanostructure.
(Photo: Future Science Prize)
AWARDS
- Future Science Prize 2020
Related articles
St. Jude Medical Expands Into Beijing, China
St. Jude Medical, Inc. today opened the St. Jude Medical Advanced Technology Center Asia Pacific in Beijing, China.
MIT And Malaysia Establish New Institute For Logistics Research
Malaysia is partnering with MIT's Center for Transportation & Logistics (MIT CTL) to create a global center for supply chain education and research.
British and Chinese Eye Movements Differ
Researchers have discovered that a type of fast eye movements, called saccades, is rare in British people but much more common in Chinese people.
Wild Migratory Geese May Have Spread H5N1 Bird Flu
A study in PLoS ONE has given the first evidence of highly pathogenic H5N1 viral transmission between domestic farms and wild birds in Tibet.
10 Asian Cities To Suffer From Perennial Water Shortages In 2050
Research reveals that more than one billion urban residents will face serious water shortages by 2050, with China and India among those most affected by water shortages.
Chinese Women In Their 40s Are Getting Breast Cancer
Chinese women who get breast cancer tend to develop the illness at a much younger age, according to a new survey conducted by the Cancer Foundation of China.
Worldwide Study: Asia’s English Proficiency Lower Than Expected
A comprehensive index ranking the proficiency of non-native English speakers has shown a correlation between English proficiency and income.
China’s Cities Focus On Climate Change
The Climate Group, an international climate action organization, and five Chinese cities aim to blaze a new trail for low carbon development during the coming three years.
Australian Company’s Anti-Anxiety Drug Shows Promise
Australian Drug development company Bionomics Limited has successfully concluded two Phase Ib clinical trials of anti-anxiety drug BNC210.